CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 107 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2019. The put-call ratio across all filers is 3.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $381 | -31.7% | 2,312 | +4.5% | 0.00% | – |
| Q2 2022 | $558 | -52.6% | 2,212 | 0.0% | 0.00% | – |
| Q1 2022 | $1,176 | -13.7% | 2,212 | 0.0% | 0.00% | – |
| Q4 2021 | $1,362 | -39.6% | 2,212 | 0.0% | 0.00% | – |
| Q3 2021 | $2,256 | -44.3% | 2,212 | 0.0% | 0.00% | – |
| Q2 2021 | $4,048 | -7.1% | 2,212 | 0.0% | 0.00% | – |
| Q1 2021 | $4,358 | +57.6% | 2,212 | 0.0% | 0.00% | – |
| Q4 2020 | $2,765 | -30.6% | 2,212 | 0.0% | 0.00% | – |
| Q3 2020 | $3,982 | -83.1% | 2,212 | -21.3% | 0.00% | -100.0% |
| Q2 2020 | $23,593 | +60.1% | 2,812 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $14,735 | +22.0% | 2,812 | +27.1% | 0.00% | 0.0% |
| Q4 2019 | $12,078 | +12.1% | 2,212 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $10,772 | – | 2,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $3,107,000 | 1.71% |
| ETF MANAGERS GROUP, LLC | 14,138,998 | $8,534,000 | 0.17% |
| Ikarian Capital, LLC | 948,526 | $584,000 | 0.09% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 318,668 | $196,000 | 0.03% |
| Platform Technology Partners | 45,000 | $28,000 | 0.01% |
| XTX Topco Ltd | 34,476 | $21,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 947,083 | $583,000 | 0.01% |
| Penserra Capital Management LLC | 537,236 | $330,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,070,006 | $2,506,000 | 0.01% |
| Tekla Capital Management LLC | 154,310 | $95,000 | 0.00% |